Canal Capital Management’s AstraZeneca AZN Stock Holding History

Canal Capital Management’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$365K	Sell	1,927 -25	-1%	-$4.7K	0.04%	168
2026 Q1	$385K	Sell	1,952 -1	-0.1%	-$193	0.05%	147
2025 Q4	$359K	Buy	1,953 +17	+0.9%	+$2.98K	0.05%	140
2025 Q3	$297K	Buy	1,936 +72	+4%	+$10.9K	0.04%	154
2025 Q2	$260K	Hold	1,864	–	–	0.04%	164
2025 Q1	$274K	Buy	1,864 +1	+0.1%	+$145	0.05%	145
2024 Q4	$244K	Hold	1,863	–	–	0.04%	151
2024 Q3	$290K	Buy	1,863 +63	+4%	+$10.2K	0.05%	135
2024 Q2	$281K	Hold	1,800	–	–	0.05%	131
2024 Q1	$244K	Hold	1,800	–	–	0.04%	133
2023 Q4	$242K	Hold	1,800	–	–	0.04%	148
2023 Q3	$244K	Hold	1,800	–	–	0.05%	138
2023 Q2	$258K	Hold	1,800	–	–	0.05%	134
2023 Q1	$250K	Hold	1,800	–	–	0.06%	135
2022 Q4	$244K	Buy	+1,800	New	+$226K	0.06%	143
2022 Q3	–	Sell	-2,052	Closed	-$271K	–	132
2022 Q2	$271K	Buy	2,052 +252	+14%	+$33.1K	0.08%	123
2022 Q1	$239K	Hold	1,800	–	–	0.06%	135
2021 Q4	$210K	Hold	1,800	–	–	0.05%	140
2021 Q3	$216K	Sell	1,800 -43	-2%	-$5K	0.06%	124
2021 Q2	$221K	Buy	+1,843	New	+$202K	0.06%	128
2020 Q4	–	Sell	-1,843	Closed	-$202K	–	123
2020 Q3	$202K	Buy	+1,843	New	+$205K	0.09%	113

Other funds holding AZN

Evelyn Partners London $46.9B AUM

Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Canal Capital Management's AZN Position: Q2 2026 in Review

Canal Capital Management reduced its AstraZeneca (AZN) stake by 1.3% in Q2 2026, selling an estimated $4.7K and leaving 1,927 shares worth $365K. The position accounts for 0.04% of the portfolio, ranked #168.

Canal Capital Management first reported a position in AZN in Q3 2020 and has held it in 21 quarters since. The position peaked at $385K in Q1 2026. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

Canal Capital Management held 1,927 shares of AstraZeneca worth $365K as of Q2 2026.
Canal Capital Management sold 25 AstraZeneca shares in Q2 2026, an estimated $4.7K.
AstraZeneca made up 0.04% of Canal Capital Management's portfolio in Q2 2026, its #168 holding.
Canal Capital Management first reported a position in AstraZeneca in Q3 2020 and has held it in 21 quarters since.
Canal Capital Management's AstraZeneca position peaked at $385K in Q1 2026.
1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Canal Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.